Sun and others, through microarray analysis, discovered the expression of the epidermal growth factor receptor (EGFR) in FDC sarcomas, with immunohistochemistry confirming moderate to strong expression of EGFR in seven out of eight FDCS cases (88%), suggesting a potential therapeutic target for some surgically challenging cases [18]. Here, EGFR is linked to sarcoma.